Enhanced platform strengthens Dash Solution’s leadership in healthcare; clinical trials business on pace to grow 20% in 2025
Dash Solutions, the leader in payments enablement, announced the expanded reach of its unified, enterprise-grade platform, which currently powers complex payment workflows for banking, government and other regulated industries. Building on this foundation, Dash Solutions is rapidly scaling in healthcare and clinical research, with the company on pace to grow its clinical trials business by 20% this year alone.
Read More on Fintech : Global Fintech Interview With Justin Meretab, Co‑Founder and CEO of Layer
“By extending our platform’s reach into healthcare and clinical research, we’re enabling organizations to modernize payment processes at scale,” says Tan Truong, COO at Dash Solutions.
The unified platform meets rising demand for modern financial infrastructure that eliminates administrative friction across highly regulated environments. With advanced capabilities, including enterprise API integrations, real-time disbursements and workflow automation, organizations can now consolidate payments operations into one, scalable system.
“Our unified platform is engineered for the complex operational demands of regulated sectors,” said Tan Truong, Chief Operating Officer at Dash Solutions. “By extending our platform’s reach into healthcare and clinical research, we’re enabling organizations to modernize payment processes at scale.”
This impact is especially evident in clinical trials, where outdated payment systems, like manual checks or delayed reimbursements, slow operations and contribute to participant attrition. Dash Solutions’ platform helps clinical research organizations (CROs) modernize participant payments to reduce this administrative overhead and improve the patient experience.
“With our clinical trials business projected to grow 20% in 2025, and accelerate even further in 2026, Dash Solutions is doubling down on digital payment solutions in this market,” said Stephen Faust, CEO of Dash Solutions. “Legacy payment systems simply can’t handle the operational demands of modern healthcare and research. Our real-time payments platform eliminates this friction, driving trial success with a technology-first, patient-centric approach.”
Dash Solutions partners with sponsors, CROs, site networks, and pharmaceutical companies to power patient stipends and reimbursement payments for nearly 1,000 clinical trial sites. The company will showcase its expanding role in clinical research payments at the upcoming SCRS Global Site Solutions Summit (Booth #817).
The platform’s unification builds on a period of record growth for Dash Solutions. In 2024, the company onboarded more than 1,000 new customers and reported a 240% increase in revenue growth since 2021. The enhanced platform now supports 10 times its previous capacity, positioning Dash Solutions for continued global expansion across healthcare and clinical trials.
Catch more Fintech Insights : The CFO’s New Analyst: Using Generative AI for Strategic Financial Modeling
[To share your insights with us, please write to psen@itechseries.com ]
